Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ZENTALIS PHARMACEUTICALS | 8 | 8 | 0,00 % | ||
| TAYSHA GENE THERAPIES | 5 | 6 | 0,00 % | ||
| BIONTECH | 4 | 28 | -0,44 % | ||
| GRIFOLS | 4 | 8 | -3,82 % | ||
| INTRA-CELLULAR THERAPIES | 4 | 5 | -1,42 % | ||
| CUREVAC | 3 | 13 | -1,32 % | ||
| PLIANT THERAPEUTICS | 3 | 6 | -5,29 % | ||
| ZAI LAB LTD ADR | 3 | 3 | -1,70 % | ||
| NOVAVAX | 2 | 17 | -1,09 % | ||
| MODERNA | 2 | 16 | -1,69 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:30 | SONDERMELDUNG: Könnte die Novavax-Aktie jetzt komplett drehen - Das müssen Sie UNBEDINGT beachten! | Hebelschein-Spekulant | |||
| 10:26 | Aktienmarkt: Aktie von Sanofi SA tritt auf der Stelle (88,20 €) | 133 | ARIVA.de | Der Kurs der der Sanofi SA-Aktie kommt kaum von der Stelle. Zuletzt zahlten Investoren für die Aktie 88,20 Euro. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich derzeit der... ► Artikel lesen | |
| 00:42 | ZAI LAB (09688): VOTING RESULTS OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| Di | DelveInsight Business Research, LLP: Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A/S, Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Rhythm Pharmaceuticals, Harmony Biosciences | 362 | PR Newswire | The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be further influenced by the extensive pipeline... ► Artikel lesen | |
| Di | Stifel starts Third Harmonic at buy, cites mast cell disease approach | 2 | Seeking Alpha | ||
| Di | Enliven Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Cantor starts Innoviva at overweight, cites diversified business model | 1 | Seeking Alpha | ||
| Di | Arcutis Biotherapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Di | Cancer Biotech Day One Biopharma Expands to ADCs, Paying $55M to Nab a Phase 1-Ready Drug | 1 | MedCity News | ||
| Di | Crinetics Pharmaceuticals, Inc.: EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner | 1 | GlobeNewswire (USA) | ||
| Di | Tarsus Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Zai Lab Ltd - S-8, Securities to be offered to employees in employee benefit plans | 4 | SEC Filings | ||
| Di | BICYCLE THERAPEUTICS PLC - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Zai Lab Ltd - 8-K, Current Report | 1 | SEC Filings | ||
| Di | GENMAB A/S - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| Di | Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years | 4 | Benzinga.com | ||
| Di | The Latest Analyst Ratings For Arcellx | 1 | Benzinga.com | ||
| Di | Check Out What Whales Are Doing With AMGN | 4 | Benzinga.com | ||
| Di | Genmab A/S: Capital Increase in Genmab as a Result of Employee Warrant Exercise | 6 | GlobeNewswire (USA) | ||
| Di | Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs | 7 | Benzinga.com |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
